Search
Search Results

No Search Results Found

LIVE
Search
Search Results

No Search Results Found

Explore HomeNewsPodcastsBreaking NewsSocial Watch Live Infowars NetworkThe Alex Jones ShowThe War Room with Owen ShroyerThe American Journal More Banned.VideoInfowars StoreArchiveRSSDownload Our App

Terms of Service

DMCA

Advertise with us

Affiliates

Media Inquiries

About

Science & Tech

Google’s parent company takes a step towards the pharmaceutical industry

by Christina Maas | Reclaim The Net
November 7th 2021, 2:05 am
Entering another market
Image Credit:
Stephen Swintek / Getty Images
Share
Share
Fund the InfoWar. Donate Now!
Keep up to date with our latest:
Email
Sign Up Now
Have an important tip? Let us know.Email us here.

Google’s parent company Alphabet is getting into yet another market and has launched another company that will use artificial intelligence (AI) to identify drug combinations for the treatment of various diseases. Alphabet already has a similar company, DeepMind.

On Thursday, Alphabet announced the launch of Isomorphic Laboratories, a new company that will use AI to discover new drugs. Alphabet’s DeepMind does similar work and has used AI to predict useful protein structures.

DeepMind’s CEO Dennis Hassabis will also be the head of Isomorphic Laboratories. However, the two are separate companies that will sometimes collaborate.

Experts have recommended AI as a way to make the discovery of new medications faster and more efficient. That explains why the medical field has invested hundreds of millions in AI over the past two years.

Dr. Peter McCullough joins The Alex Jones Show to issue a warning to the public and expose corruption behind the growing medical tyranny state.

Isomorphic Laboratories will focus on building AI models that can predict how potential medication can interact with the body, explained Hassabis. That could be accomplished by building on DeepMind’s progress in structure of proteins, which could help predict how different proteins interact.

Google’s parent company Alphabet is getting into yet another market and has launched another company that will use artificial intelligence (AI) to identify drug combinations for the treatment of various diseases. Alphabet already has a similar company, DeepMind.

On Thursday, Alphabet announced the launch of Isomorphic Laboratories, a new company that will use AI to discover new drugs. Alphabet’s DeepMind does similar work and has used AI to predict useful protein structures.

DeepMind’s CEO Dennis Hassabis will also be the head of Isomorphic Laboratories. However, the two are separate companies that will sometimes collaborate.

Experts have recommended AI as a way to make the discovery of new medications faster and more efficient. That explains why the medical field has invested hundreds of millions in AI over the past two years.

Isomorphic Laboratories will focus on building AI models that can predict how potential medication can interact with the body, explained Hassabis. That could be accomplished by building on DeepMind’s progress in structure of proteins, which could help predict how different proteins interact.

Google’s parent company Alphabet is getting into yet another market and has launched another company that will use artificial intelligence (AI) to identify drug combinations for the treatment of various diseases. Alphabet already has a similar company, DeepMind.

On Thursday, Alphabet announced the launch of Isomorphic Laboratories, a new company that will use AI to discover new drugs. Alphabet’s DeepMind does similar work and has used AI to predict useful protein structures.

DeepMind’s CEO Dennis Hassabis will also be the head of Isomorphic Laboratories. However, the two are separate companies that will sometimes collaborate.

Experts have recommended AI as a way to make the discovery of new medications faster and more efficient. That explains why the medical field has invested hundreds of millions in AI over the past two years.

Isomorphic Laboratories will focus on building AI models that can predict how potential medication can interact with the body, explained Hassabis. That could be accomplished by building on DeepMind’s progress in structure of proteins, which could help predict how different proteins interact.

A spokesperson told The Verge that the company might not develop its own medications. It will sell its models and form partnerships with pharmaceutical companies.

FEATURED BANNED VIDEOS
In case you missed it...
Science & Tech

Science & Tech

Fury as transgender UPenn swimmer who used to compete as a man smashes TWO US women’s records and finishes one race 38 seconds ahead of her nearest rival

posted a day ago

Science & Tech

Babies Hospitalized After Getting Covid-19 Vaccine

posted 2 days ago

Science & Tech

Robots Are Now Able To Replicate — What Does This Mean For Humanity?

posted 3 days ago

Science & Tech

German Doctor Murdered Hours After Exposing Graphene Hydroxide In Vaccines — See Video Here

posted 4 days ago

View More From Science & Tech
Terms of ServiceDMCAAdvertise with usAffiliatesMedia InquiriesAbout